Posters
« Back
Primary Screening of a 1564 Compound Focused Diversity set Against the Human Cardiac Sodium Channel Nav1.5 Using the IonWorks Quattro System
EP20313
Poster Title: Primary Screening of a 1564 Compound Focused Diversity set Against the Human Cardiac Sodium Channel Nav1.5 Using the IonWorks Quattro System
Submitted on 19 Dec 2013
Author(s): James Costantin, Shawn Handran, David Yamane, Naibo Yang
Affiliations: Molecular Devices
Poster Views: 915
View poster »


Poster Information
Abstract: Population Patch Clamp™ (PPC) technology was recently introduced byMolecular Devices in the IonWorks™ Quattro system. PPC records from up to 64 cells at a time, and greatly reduces biological variability, achieving nearly 100% success rates and highly consistent data quality (Z’-Factors between 0.6 – 0.8). We conducted a feasibility study for using the IonWorks Quattro system in a primary screen of a focused library (1564 compounds) for modulators of the cardiac sodium channel Nav1.5 (hH1) –an important target for anti-arrhythmia therapeutics.

The screen was carried out in duplicate at a single concentration (10 uM) in less than two working days. There were 37 actives with 50% or more inhibition identified (2.4% hit rate), which were all followed-up for potency (10-point dose-response run in duplicate) and selectivity (counter screened against Kv1.3). A number of compounds show use dependence and selectivity.

This rapid assay campaign demonstrates that the IonWorks Quattro system can be used for directed primary screens of voltage-gated ion channel modulators. The daily throughput of the IonWorks Quattro is >2000 data points per day. It is estimated that a 10,000 compound single-point screen with follow-up pharmacology could be completed in approximately 2-4 working weeks.
Summary: We conducted a feasibility study for using the IonWorks™ Quattro system in a primary screen of a focused library (1564 compounds) for modulators of the cardiac sodium channel Nav1.5 (hH1), an important target for anti-arrhythmia therapeutics.Report abuse »
Creative Commons

Related Posters


Plant Extract
Tylor Keller

3D Printing Materials
Tylor Keller

Chemical Fluorescence Probe
Tylor Keller

low-volume workflows improve the quality of drug discovery: two case studies
Margaret Kenney#, Archi Joardar#, Vasudeo Badarinarayana#, Joby Jenkins*

Dissecting the genomic profile of persistently infecting oncolytic Newcastle disease virus (NDVpi) from cancer RNA-Seq data
Ahmad U1, Chan SC2, Chau DM1, Chia SL5, Abdullah S1,3, Yusoff K5 & Veerakumarasivam A1,4*